title: Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine: part 2.
authors.affiliation: Section of Urologic Oncology, Glickman Urological Institute, Cleveland, OH 44195, USA.
authors.forename: Ryan K
authors.initials: RK
authors.lastname: Berglund
authors.forename: Sean P
authors.initials: SP
authors.lastname: Lyden
authors.forename: Eve C
authors.initials: EC
authors.lastname: Tsai
authors.forename: Isador
authors.initials: I
authors.lastname: Lieberman
authors.forename: Eric A
authors.initials: EA
authors.lastname: Klein
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000601:surgery; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D013125:Spinal Neoplasms / Q000556:secondary*; D013724:Teratoma / Q000188:drug therapy / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents